Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126770621 | 12677062 | 1 | I | 2014 | 20140416 | 20160823 | 20160823 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-17513BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 113.40000 | KG | 20160823 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126770621 | 12677062 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 406589 | 22512 | 150 | MG | CAPSULE | BID | |||||
| 126770621 | 12677062 | 2 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
| 126770621 | 12677062 | 3 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | 0 | ||||||||||||
| 126770621 | 12677062 | 4 | C | FISH OIL | FISH OIL | 1 | Oral | 0 | QD | ||||||||||
| 126770621 | 12677062 | 5 | C | FLAXSEED | FLAX SEED | 1 | Oral | 0 | |||||||||||
| 126770621 | 12677062 | 6 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | TABLET | QD | |||||||||
| 126770621 | 12677062 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG | 0 | 50 | MG | TABLET | QD | ||||||
| 126770621 | 12677062 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 126770621 | 12677062 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | QD | ||||||||||
| 126770621 | 12677062 | 10 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.25 MG | 0 | .25 | MG | QD | |||||||
| 126770621 | 12677062 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 126770621 | 12677062 | 12 | C | MULTIPLE VITAMIN | VITAMINS | 1 | Oral | 1 ANZ | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126770621 | 12677062 | 1 | Atrial fibrillation |
| 126770621 | 12677062 | 2 | Hypertension |
| 126770621 | 12677062 | 3 | Fluid retention |
| 126770621 | 12677062 | 4 | Supplementation therapy |
| 126770621 | 12677062 | 5 | Supplementation therapy |
| 126770621 | 12677062 | 6 | Mineral supplementation |
| 126770621 | 12677062 | 7 | Atrial fibrillation |
| 126770621 | 12677062 | 9 | Vitamin supplementation |
| 126770621 | 12677062 | 10 | Atrial fibrillation |
| 126770621 | 12677062 | 11 | Blood cholesterol increased |
| 126770621 | 12677062 | 12 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126770621 | 12677062 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126770621 | 12677062 | Breast cancer | |
| 126770621 | 12677062 | Burning sensation | |
| 126770621 | 12677062 | Dyspepsia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126770621 | 12677062 | 1 | 201402 | 0 | ||
| 126770621 | 12677062 | 2 | 1980 | 0 | ||
| 126770621 | 12677062 | 8 | 2014 | 0 | ||
| 126770621 | 12677062 | 10 | 2014 | 0 | ||
| 126770621 | 12677062 | 11 | 2015 | 0 |